[In vitro susceptibilities of Helicobacter pylori strains from children to proton pump inhibitors and its thioether derivative].
Taneike
I
I
Department of Bacteriology, School of Medicine, Niigata University.
Tamura
Y
Y
Shimizu
T
T
Yamashiro
Y
Y
Toyoda
S
S
Yamamoto
T
T
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001562:Benzimidazoles / Q000494:pharmacology; D002675:Child, Preschool; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D016480:Helicobacter pylori / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D064747:Lansoprazole; D009853:Omeprazole / Q000031:analogs & derivatives / Q000494:pharmacology; D017494:Proton Pumps / Q000187:drug effects*; D064750:Rabeprazole; D013440:Sulfides / Q000494:pharmacology
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D004791:Enzyme Inhibitors; D017494:Proton Pumps; D013440:Sulfides; D064747:Lansoprazole; D064750:Rabeprazole; D009853:Omeprazole